OI→SB2 (n=7) | Historical OI (n=6) | |
---|---|---|
Age, mean (SD) | 53.1 (4.9) | 47.1 (4.9) |
Female | 2 | 5 |
Spondylarthropathy | 6 | 4 |
BASDAI, mean (SD) | 26.3 (8.8) | 63 (9.6) |
Rheumatoid arthritis | 1 | 3 |
DAS28 CRP, mean (SD) | 0.96 | 2.9 (0.4) |
Methotrexate | 1 | 3 |
Fibromyalgia | 0 | 1 |
Anxiety-depression | 1 | 2 |
Time under OI (month), mean (SD) | 104.8 (22.6) | 49.3 (11.2) |
IFX dose (mg/kg), mean (SD) | 4.6 (0.08) | 4.6 (0.3) |
Infusion rhythm (weeks), mean (SD) | 7.5 (0.1) | 7 (0.44) |
IFX, Infliximab; OI, Originator infliximab Remicade.